Table 3.

Left section: Imputed odds ratios for SCC according to level of HPV16 viral load compared to HPV16-negative women over ten years before diagnosis. Right section: Imputed odds ratios for SCC according to HPV16-positivity and high-risk HPV positivity over ten years before diagnosis. Note the different reference levels for the different analyses.

HPV16 viral load and risk of squamous cell carcinoma (SCC)				HPV16-positivity and HR-HPV-positivity and risk of SCC
Year before diagnosis	HPV16 negative (reference)	Low/medium HPV16 viral load (OR, 95% CI)	High HPV16 viral load (OR, 95% CI)	Year before diagnosis	HPV16 positive Ref: HPV16-negative (OR, 95% CI)	High-risk HPV positive Ref: High-risk HPV-negative (OR, 95% CI)
1	1.0	22 (6 - 81)	70 (8 - 628)	1	20 (8 - 50)	29 (12 - 72)
2	1.0	25 (6 - 104)	61 (7 - 547)	2	18 (8 - 43)	22 (10 - 49)
3	1.0	39 (8 - 202)	60 (6 - 580)	3	20 (8 - 50)	20 ( 9 - 43)
4	1.0	32 (7 - 159)	34 (4 - 271)	4	17 (7 - 39)	17 ( 9 - 36)
5	1.0	26 (6 - 112)	23 (4 - 119)	5	17 (8 - 38)	16 ( 8 - 32)
6	1.0	17 (6 - 50)	20 (3 - 139)	6	12 (6 - 26)	11 ( 6 - 20)
7	1.0	13 (5 - 35)	22 (3 - 154)	7	9 (5 - 17)	8 ( 5 - 14)
8	1.0	14 (5 - 38)	11 (2 - 54)	8	9 (4 - 17)	7 ( 4 - 12)
9	1.0	12 (5 - 33)	7 (2 - 27)	9	8 (4 - 17)	9 ( 5 - 15)
10	1.0	9 (3 - 23)	10 (2 - 57)	10	8 (4 - 15)	7 ( 4 - 13)